p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.

作者: Jeremy P Blaydes , John N Primrose , Matthew Darley , Monika Phelps

DOI:

关键词:

摘要: The negative-regulatory feedback loop between p53 and hdm2 forms part of a finely balanced regulatory network proteins that controls cell cycle progression commitment to apoptosis. Expression hdm2, its mouse orthologue mdm2, is known be induced by p53, but recent evidence has demonstrated mdm2 expression can also regulated via p53-independent pathways. However the independent mechanisms control transcription human gene have not been studied. Differential levels mRNA protein reported in several types malignancy, including breast cancers which correlates with positive estrogen receptor alpha (ERalpha) status. Experimental models overexpression promote cancer development. Here, we show elevated level ERalpha(+ve) lines such as MCF-7 T47D because from p53-inducible P2 promoter hdm2. inactive ERalpha(-ve) SKBr3. Hdm2-P2 activity cells well regulators mdm2-P2 promoter, ERalpha ras-raf-mitogen-activated protein/extracellular signal-regulated kinase (MEK) mitogen-activated (MAPK) signaling. We hdm2-P2 dependent on integrity both an evolutionarily conserved composite binding site for AP1 ETS family factors (AP1-ETS) nonconserved upstream (nnGGGGC)(5) repeat sequence. Lack shown consequence reduced transcriptional activation through AP1-ETS element. Overexpression ETS2 SKBr3 reconstitutes element-dependent activity, resulting increased cells. Our findings support hypothesis tumors play important role development these tumors.

参考文章(59)
Ole W. Petersen, Lone Rønnov-Jessen, Valerie M. Weaver, Mina J. Bissell, Differentiation and Cancer in the Mammary Gland: Shedding Light on an Old Dichotomy Advances in Cancer Research. ,vol. 75, pp. 135- 162 ,(1998) , 10.1016/S0065-230X(08)60741-1
Venu Raman, Shelby A. Martensen, David Reisman, Ella Evron, Ward F. Odenwald, Elizabeth Jaffee, Jeffrey Marks, Saraswati Sukumar, Compromised HOXA5 function can limit p53 expression in human breast tumours Nature. ,vol. 405, pp. 974- 978 ,(2000) , 10.1038/35016125
Barbara J. Graves, Jeannine M. Petersen, Specificity within the ets Family of Transcription Factors Advances in Cancer Research. ,vol. 75, pp. 1- 57 ,(1998) , 10.1016/S0065-230X(08)60738-1
A Zauberman, M Oren, Y Barak, D L George, T Juven, Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene Oncogene. ,vol. 8, pp. 3411- 3416 ,(1993)
Bert Vogelstein, David Lane, Arnold J. Levine, Surfing the p53 network Nature. ,vol. 408, pp. 307- 310 ,(2000) , 10.1038/35042675
J Chen, V Marechal, A J Levine, Mapping of the p53 and mdm-2 interaction domains. Molecular and Cellular Biology. ,vol. 13, pp. 4107- 4114 ,(1993) , 10.1128/MCB.13.7.4107
Kiyoko Kato, Shinji Horiuchi, Akira Takahashi, Yousuke Ueoka, Takahiro Arima, Takao Matsuda, Hidenori Kato, Jun-ichi Nishida, Yusaku Nakabeppu, Norio Wake, Contribution of Estrogen Receptor α to Oncogenic K-Ras-mediated NIH3T3 Cell Transformation and Its Implication for Escape from Senescence by Modulating the p53 Pathway Journal of Biological Chemistry. ,vol. 277, pp. 11217- 11224 ,(2002) , 10.1074/JBC.M107391200
Jeremy P Blaydes, Ted R Hupp, DNA Damage Triggers DRB-resistant Phosphorylation of Human p53 at the CK2 Site Oncogene. ,vol. 17, pp. 1045- 1052 ,(1998) , 10.1038/SJ.ONC.1202014
Sigurdur Ingvarsson, Molecular genetics of breast cancer progression Seminars in Cancer Biology. ,vol. 9, pp. 277- 288 ,(1999) , 10.1006/SCBI.1999.0124
Wenge Lu, Radhika Pochampally, Lihong Chen, Mullika Traidej, Yiliang Wang, Jiandong Chen, Nuclear exclusion of p53 in a subset of tumors requires MDM2 function Oncogene. ,vol. 19, pp. 232- 240 ,(2000) , 10.1038/SJ.ONC.1203262